TRENEISE HUNT-SMITH: Open Payments
NPI 1831728583 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$701 in 14 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $358 · 2025 $701
Food & beverage: $701
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $148 |
| Gilead Sciences, Inc. | 2 | $133 |
| Novo Nordisk Inc | 1 | $113 |
| Teva Pharmaceuticals USA, Inc. | 1 | $100 |
| Lilly USA, LLC | 1 | $86 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Theratechnologies Inc. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Exact Sciences Corporation | 1 | $15 |
Products named: VRAYLAR, Wegovy, UZEDY, ZEPBOUND, AIRSUPRA, EGRIFTA, QULIPTA, Kerendia.
Industry payments across TN — which companies pay providers there.
